Repligen
RGEN
#2045
Rank
ยฃ6.96 B
Marketcap
ยฃ123.76
Share price
-0.47%
Change (1 day)
11.00%
Change (1 year)
Categories

Repligen (RGEN) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.56 Billion

According to Repligen 's latest financial reports the company has ยฃ0.56 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Repligen - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.60 B2.34%
2023-12-31ยฃ0.58 B14.38%
2022-12-31ยฃ0.51 B15.26%
2021-12-31ยฃ0.44 B-15%
2020-12-31ยฃ0.52 B30.59%
2019-12-31ยฃ0.40 B163.9%
2018-12-31ยฃ0.15 B18.77%
2017-12-31ยฃ0.12 B11.89%
2016-12-31ยฃ0.11 B137.24%
2015-12-31ยฃ48.43 M29%
2014-12-31ยฃ37.54 M0.5%
2013-12-31ยฃ37.35 M50.75%
2012-12-31ยฃ24.78 M
2011-03-31ยฃ30.94 M-10.93%
2010-03-31ยฃ34.74 M2.84%
2009-03-31ยฃ33.78 M36.33%
2008-03-31ยฃ24.78 M114.96%
2007-03-31ยฃ11.52 M5.56%
2006-03-31ยฃ10.92 M19.57%
2005-03-31ยฃ9.13 M21.52%
2004-03-31ยฃ7.51 M-23.68%
2003-03-31ยฃ9.84 M-32.65%
2002-03-31ยฃ14.62 M-13.56%
2001-03-31ยฃ16.91 M-20.79%
2000-03-31ยฃ21.35 M944.99%
1999-03-31ยฃ2.04 M-27.1%
1998-03-31ยฃ2.8 M31.75%
1997-03-31ยฃ2.12 M-52.99%
1996-03-31ยฃ4.52 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novavax
NVAX
ยฃ0.57 B 1.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.10 B 97.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.83 B 48.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ10.13 B 1,704.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ2.66 B 373.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ12.37 B 2,103.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ11.24 B 1,901.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ0.10 B-80.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ22.21 M-96.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
ยฃ0.15 B-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA